News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
ERYtech Pharma Reinforces its Supervisory Board and its Scientific Board
October 30, 2009
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
LYON, France & PHILADELPHIA--(BUSINESS WIRE)--The new members of the Supervisory Board are: Sven Andréasson, MBA. Permanent representative of Galenos SPRL, Independent Director, he is the CEO of Beta-Cell NV in Brussels.
Twitter
LinkedIn
Facebook
Email
Print
People
Europe
MORE ON THIS TOPIC
Business
Deep dive: Pharma CEO compensation report
June 30, 2026
·
1 min read
·
Annalee Armstrong
Layoff Tracker
BioCryst ends all internal discovery efforts
June 30, 2026
·
64 min read
·
BioSpace Editorial Staff
FDA
FDA’s cell and gene therapy head steps down after 1 year
June 30, 2026
·
2 min read
·
Michael Gibney
China
Deerfield bets up to $1.6B to snag autoimmune asset in China for Boulevard
June 30, 2026
·
1 min read
·
Annalee Armstrong